Susceptibility of human Plasmodium knowlesi infections to anti-malarials by Farrah, A Fatih et al.
Fatih et al. Malaria Journal 2013, 12:425
http://www.malariajournal.com/content/12/1/425RESEARCH Open AccessSusceptibility of human Plasmodium knowlesi
infections to anti-malarials
Farrah A Fatih1, Henry M Staines1, Angela Siner2, Mohammed Atique Ahmed2, Lu Chan Woon3, Erica M Pasini4,
Clemens HM Kocken4, Balbir Singh2, Janet Cox-Singh2,5 and Sanjeev Krishna1,2*Abstract
Background: Evidence suggests that Plasmodium knowlesi malaria in Sarawak, Malaysian Borneo remains zoonotic,
meaning anti-malarial drug resistance is unlikely to have developed in the absence of drug selection pressure.
Therefore, adequate response to available anti-malarial treatments is assumed.
Methods: Here the ex vivo sensitivity of human P. knowlesi isolates in Malaysian Borneo were studied, using a WHO
schizont maturation assay modified to accommodate the quotidian life cycle of this parasite. The in vitro sensitivities
of P. knowlesi H strain adapted from a primate infection to in vitro culture (by measuring the production of
Plasmodium lactate dehydrogenase) were also examined together with some assays using Plasmodium falciparum
and Plasmodium vivax.
Results: Plasmodium knowlesi is uniformly highly sensitive to artemisinins, variably and moderately sensitive to
chloroquine, and less sensitive to mefloquine.
Conclusions: Taken together with reports of clinical failures when P. knowlesi is treated with mefloquine, the data
suggest that caution is required if using mefloquine in prevention or treatment of P. knowlesi infections, until
further studies are undertaken.
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From its natural simian hosts in Southeast Asia, Plasmo-
dium knowlesi has emerged as a significant human
pathogen, particularly in Malaysian Borneo [1-3]. Human
P. knowlesi infections cause febrile illnesses that can rap-
idly progress to severe and sometimes fatal outcomes [4].
Ominously, the incidence of P. knowlesi malaria is increas-
ing in geographic areas where Plasmodium falciparum
and Plasmodium vivax are coming under control, thereby
threatening the aim of eliminating malaria [5]. Deter-
mining the efficacy of conventional anti-malarials against
P. knowlesi is a priority, particularly as there are no
reports of anti-malarials assessed against human isolates of
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stated.Here, the drug sensitivity profiles of P. knowlesi isolates
obtained from patients being recruited into a study of the
pathophysiology of knowlesi malaria in an endemic area of
Sarawak, Malaysian Borneo were investigated. Currently,
the WHO recommends artemisinin-based combination
therapy (ACT) as first-line treatment for malaria in most
endemic areas, so artemisinin and its clinically useful de-
rivatives artesunate, dihydroartemisinin (DHA) and arte-
mether were tested. Mefloquine, used as a partner drug in
certain artemisinin-based combinations and in prophylaxis
against malaria, and chloroquine that is recommended for
treatment of Plasmodium malariae (the species which
P. knowlesi is often confused with when diagnosed by
microscopy) were also included. In addition, results from
P. falciparum and P. vivax studied contemporaneously
are presented, together with those obtained with the H
strain laboratory isolate of P. knowlesi (cultured in vitro
in rhesus erythrocytes) to confirm the methodologies
used. Insights into the drug susceptibility patterns of this
important emerging parasite, may prove useful in guidingd. This is an Open Access article distributed under the terms of the Creative
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